Answers are grounded in this paper and cite their sources.
Prospective observational study shows improved outcomes in haemophilia A children after transitioning to efanesoctocog alfa, suggesting clinical benefits.
BACKGROUND: Efanesoctocog alfa is a novel recombinant factor VIII (FVIII) with an ultra-extended half-life and stable pharmacokinetics, approved for prophylaxis in children with haemophilia A (HA). OBJECTIVE: To describe the experience of transitioning paediatric patients with HA to efanesoctocog alfa using a comprehensive assessment. METHODS: Prospective observational study in a paediatric haemophilia unit. Patients <18 years without inhibitors were transitioned from prior prophylaxis to efanesoctocog alfa. Treatment regimen, adherence, annual bleeding rate (ABR), pharmacokinetics, joint health, sports, quality-of-life, treatment burden, treatment satisfaction/preference were compared at baseline and during follow-up between efanesoctocog alfa and previous treatment. RESULTS: Eighteen patients (mean age 9.42 years) were included. After 365 ± 84.08 days, adherence improved and no inhibitors were detected. A significant increase in half-life was observed (from 13.57 ± 3.6 to 57.13 ± 6.1 h) which led to a lower ABR score in the series (0.39-0.05) and an improvement of joint health after 6 months (n = 15 patients), due to a relevant synovitis reduction (20% reduction in elbows; 13.3% in ankles) despite patients were moderately-highly physically active. Quality-of-life perception improved after 3 months (EQ-VAS increased: 90.72 ± 10.31 to 95.25 ± 5.3; p = 0.03) as well as treatment burden (HEMO-TEM global score in 12-18 year-old patients: 16.08 ± 11.43 to 11.72 ± 14.8). Patients/caregivers expressed a strong preference for efanesoctocog alfa. CONCLUSION: Transitioning to efanesoctocog alfa was safe and effective in this paediatric cohort. Despite limited follow-up, data suggest this therapy offers meaningful clinical and psychosocial benefits.
No takes yet. Share an insight, caveat, or question.
Berrueco et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: